{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:27:55Z","timestamp":1794493675955,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cryptochromes are negative transcriptional regulators of the circadian clock in mammals. It is not clear how reducing the level of endogenous CRY1 in mammals will affect circadian rhythm and the relation of such a decrease with apoptosis. Here, we discovered a molecule (M47) that destabilizes Cryptochrome 1 (CRY1) both in vitro and in vivo. The M47 selectively enhanced the degradation rate of CRY1 by increasing its ubiquitination and resulted in increasing the circadian period length of U2OS\n                    <jats:italic>Bmal1<\/jats:italic>\n                    -d\n                    <jats:italic>Luc<\/jats:italic>\n                    cells. In addition, subcellular fractionation studies from mice liver indicated that M47 increased degradation of the CRY1 in the nucleus. Furthermore, M47-mediated CRY1 reduction enhanced oxaliplatin-induced apoptosis in Ras-transformed\n                    <jats:italic>p53<\/jats:italic>\n                    null fibroblast cells. Systemic repetitive administration of M47 increased the median lifespan of\n                    <jats:italic>p53<\/jats:italic>\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice by ~25%. Collectively our data suggest that M47 is a promising molecule to treat forms of cancer depending on the\n                    <jats:italic>p53<\/jats:italic>\n                    mutation.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-34582-1","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T11:13:04Z","timestamp":1667905984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5613-1339","authenticated-orcid":false,"given":"Seref","family":"Gul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1734-8340","authenticated-orcid":false,"given":"Yasemin Kubra","family":"Akyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Melis","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-5257","authenticated-orcid":false,"given":"Safak","family":"Isin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-3554","authenticated-orcid":false,"given":"Onur","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-1384","authenticated-orcid":false,"given":"Saba","family":"Selvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Danis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgecan Savlug","family":"Ipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Aygenli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Cihan","family":"Taskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra Ayt\u00fcl","family":"Akarlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-8780","authenticated-orcid":false,"given":"Nurhan","family":"Ozlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5206-4127","authenticated-orcid":false,"given":"Nuri","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duri\u015fehvar \u00d6zer","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Guzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4769-6714","authenticated-orcid":false,"given":"Metin","family":"Turkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Okyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-3505","authenticated-orcid":false,"given":"Ibrahim Halil","family":"Kavakli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"34582_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-12-387690-4.00006-4","volume":"74","author":"PL Lowrey","year":"2011","unstructured":"Lowrey, P. L. & Takahashi, J. S. Genetics of circadian rhythms in Mammalian model organisms. Adv. Genet. 74, 175\u2013230 (2011).","journal-title":"Adv. Genet."},{"key":"34582_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrg2430","volume":"9","author":"JS Takahashi","year":"2008","unstructured":"Takahashi, J. S., Hong, H. K., Ko, C. H. & McDearmon, E. L. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet. 9, 764\u2013775 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"34582_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2008.08.022","volume":"134","author":"CB Green","year":"2008","unstructured":"Green, C. B., Takahashi, J. S. & Bass, J. The meter of metabolism. Cell 134, 728\u2013742, https:\/\/doi.org\/10.1016\/j.cell.2008.08.022 (2008).","journal-title":"Cell"},{"key":"34582_CR4","doi-asserted-by":"publisher","unstructured":"Marcheva, B. et al. Circadian clocks and metabolism. Handb Exp. Pharmacol. 127\u2013155, https:\/\/doi.org\/10.1007\/978-3-642-25950-0_6 (2013).","DOI":"10.1007\/978-3-642-25950-0_6"},{"key":"34582_CR5","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1172\/JCI135500","volume":"130","author":"OE Onat","year":"2020","unstructured":"Onat, O. E. et al. Human CRY1 variants associate with attention deficit\/hyperactivity disorder. J. Clin. Invest. 130, 3885\u20133900 (2020).","journal-title":"J. Clin. Invest."},{"key":"34582_CR6","doi-asserted-by":"publisher","first-page":"45921","DOI":"10.1074\/jbc.M107726200","volume":"276","author":"EL Vielhaber","year":"2001","unstructured":"Vielhaber, E. L., Duricka, D., Ullman, K. S. & Virshup, D. M. Nuclear export of mammalian PERIOD proteins. J. Biol. Chem. 276, 45921\u201345927 (2001).","journal-title":"J. Biol. Chem."},{"key":"34582_CR7","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2013.01.054","volume":"152","author":"A Hirano","year":"2013","unstructured":"Hirano, A. et al. FBXL21 Regulates Oscillation of the Circadian Clock through Ubiquitination and Stabilization of Cryptochromes. Cell 152, 1106\u20131118 (2013).","journal-title":"Cell"},{"key":"34582_CR8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.cell.2013.01.055","volume":"152","author":"SH Yoo","year":"2013","unstructured":"Yoo, S. H. et al. Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm. Cell 152, 1091\u20131105 (2013).","journal-title":"Cell"},{"key":"34582_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi, J. S. Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet. 18, 164\u2013179 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"34582_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cmet.2017.03.019","volume":"25","author":"SY Krishnaiah","year":"2017","unstructured":"Krishnaiah, S. Y. et al. Clock regulation of metabolites reveals coupling between transcription and metabolism. Cell Metab. 25, 961\u2013974 e964 (2017).","journal-title":"Cell Metab."},{"key":"34582_CR11","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1073\/pnas.1408886111","volume":"111","author":"R Zhang","year":"2014","unstructured":"Zhang, R., Lahens, N. F., Ballance, H. I., Hughes, M. E. & Hogenesch, J. B. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc. Natl Acad. Sci. USA 111, 16219\u201316224 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34582_CR12","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1158\/0008-5472.CAN-05-1119","volume":"65","author":"MA Gauger","year":"2005","unstructured":"Gauger, M. A. & Sancar, A. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 65, 6828\u20136834 (2005).","journal-title":"Cancer Res."},{"key":"34582_CR13","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1073\/pnas.0813028106","volume":"106","author":"N Ozturk","year":"2009","unstructured":"Ozturk, N., Lee, J. H., Gaddameedhi, S. & Sancar, A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc. Natl Acad. Sci. 106, 2841 (2009).","journal-title":"Proc. Natl Acad. Sci."},{"key":"34582_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1073\/pnas.1118034108","volume":"109","author":"Z Chen","year":"2012","unstructured":"Chen, Z. et al. Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening. Proc. Natl Acad. Sci. USA 109, 101\u2013106 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34582_CR15","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1074\/jbc.RA119.011332","volume":"295","author":"YU Doruk","year":"2020","unstructured":"Doruk, Y. U. et al. A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude. J. Biol. Chem. 295, 3518\u20133531 (2020).","journal-title":"J. Biol. Chem."},{"key":"34582_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1223710","volume":"337","author":"T Hirota","year":"2012","unstructured":"Hirota, T. et al. Identification of small molecule activators of cryptochrome. Science 337, 1094\u20131097 (2012).","journal-title":"Science"},{"key":"34582_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature11030","volume":"485","author":"LA Solt","year":"2012","unstructured":"Solt, L. A. et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 485, 62\u201368 (2012).","journal-title":"Nature"},{"key":"34582_CR18","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1002\/anie.201502942","volume":"54","author":"T Oshima","year":"2015","unstructured":"Oshima, T. et al. C-H activation generates period-shortening molecules that target cryptochrome in the mammalian circadian clock. Angew. Chem. Int Ed. Engl. 54, 7193\u20137197 (2015).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"34582_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41589-020-0505-1","volume":"16","author":"S Miller","year":"2020","unstructured":"Miller, S. et al. Isoform-selective regulation of mammalian cryptochromes. Nat. Chem. Biol. 16, 676\u2013685 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"34582_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cmet.2016.03.007","volume":"23","author":"B He","year":"2016","unstructured":"He, B. et al. The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome. Cell Metab. 23, 610\u2013621 (2016).","journal-title":"Cell Metab."},{"key":"34582_CR21","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.cell.2013.05.011","volume":"153","author":"A Czarna","year":"2013","unstructured":"Czarna, A. et al. Structures of drosophila cryptochrome and mouse cryptochrome1 provide insight into circadian function. Cell 153, 1394\u20131405 (2013).","journal-title":"Cell"},{"key":"34582_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.cell.2014.03.057","volume":"157","author":"I Schmalen","year":"2014","unstructured":"Schmalen, I. et al. Interaction of circadian clock proteins CRY1 and PER2 is modulated by zinc binding and disulfide bond formation. Cell 157, 1203\u20131215 (2014).","journal-title":"Cell"},{"key":"34582_CR23","doi-asserted-by":"publisher","first-page":"64-+","DOI":"10.1038\/nature11964","volume":"496","author":"WM Xing","year":"2013","unstructured":"Xing, W. M. et al. SCFFBXL3 ubiquitin ligase targets cryptochromes at their cofactor pocket. Nature 496, 64-+ (2013).","journal-title":"Nature"},{"key":"34582_CR24","doi-asserted-by":"publisher","unstructured":"Gul, S. & Kavakli, I. H. The structure-based molecular-docking screen against core clock proteins to identify small molecules to modulate the circadian clock. In: Solanas, G., Welz, P.S. (eds) Circadian Regulation. Humana, New York, NY. Methods Mol. Biol. 2482, https:\/\/doi.org\/10.1007\/978-1-0716-2249-0_2 (2022).","DOI":"10.1007\/978-1-0716-2249-0_2"},{"key":"34582_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97962-5","volume":"11","author":"S Gul","year":"2021","unstructured":"Gul, S. et al. Structure-based design and classifications of small molecules regulating the circadian rhythm period. Sci. Rep. 11, 18510 (2021).","journal-title":"Sci. Rep."},{"key":"34582_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/php.12669","volume":"93","author":"IH Kavakli","year":"2017","unstructured":"Kavakli, I. H. et al. The photolyase\/cryptochrome family of proteins as DNA repair enzymes and transcriptional repressors. Photochem. Photobio. 93, 93\u2013103 (2017).","journal-title":"Photochem. Photobio."},{"key":"34582_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski, C. A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharm. Toxicol. Methods 44, 235\u2013249 (2000).","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"34582_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2007.02.047","volume":"129","author":"AC Liu","year":"2007","unstructured":"Liu, A. C. et al. Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell 129, 605\u2013616 (2007).","journal-title":"Cell"},{"key":"34582_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1101\/gad.512209","volume":"23","author":"B Maier","year":"2009","unstructured":"Maier, B. et al. A large-scale functional RNAi screen reveals a role for CK2 in the mammalian circadian clock. Genes Dev. 23, 708\u2013718 (2009).","journal-title":"Genes Dev."},{"key":"34582_CR30","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/19323","volume":"398","author":"GT van der Horst","year":"1999","unstructured":"van der Horst, G. T. et al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 398, 627\u2013630 (1999).","journal-title":"Nature"},{"key":"34582_CR31","doi-asserted-by":"publisher","first-page":"12114","DOI":"10.1073\/pnas.96.21.12114","volume":"96","author":"MH Vitaterna","year":"1999","unstructured":"Vitaterna, M. H. et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc. Natl Acad. Sci. USA 96, 12114\u201312119 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34582_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cell.2009.08.031","volume":"139","author":"EE Zhang","year":"2009","unstructured":"Zhang, E. E. et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 139, 199\u2013210 (2009).","journal-title":"Cell"},{"key":"34582_CR33","doi-asserted-by":"publisher","first-page":"25917","DOI":"10.1074\/jbc.M112.368001","volume":"287","author":"SK Khan","year":"2012","unstructured":"Khan, S. K. et al. Identification of a novel cryptochrome differentiating domain required for feedback repression in circadian clock function. J. Biol. Chem. 287, 25917\u201325926 (2012).","journal-title":"J. Biol. Chem."},{"key":"34582_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fphys.2019.00577","volume":"10","author":"T Bording","year":"2019","unstructured":"Bording, T., Abdo, A. N., Maier, B., Gabriel, C. & Kramer, A. Generation of human CRY1 and CRY2 knockout cells using duplex CRISPR\/Cas9 technology. Front Physiol. 10, 577 (2019).","journal-title":"Front Physiol."},{"key":"34582_CR35","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1126\/science.1141194","volume":"316","author":"L Busino","year":"2007","unstructured":"Busino, L. et al. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science 316, 900\u2013904 (2007).","journal-title":"Science"},{"key":"34582_CR36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1126\/science.1141138","volume":"316","author":"SI Godinho","year":"2007","unstructured":"Godinho, S. I. et al. The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science 316, 897\u2013900 (2007).","journal-title":"Science"},{"key":"34582_CR37","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2007.04.030","volume":"129","author":"SM Siepka","year":"2007","unstructured":"Siepka, S. M. et al. Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell 129, 1011\u20131023 (2007).","journal-title":"Cell"},{"key":"34582_CR38","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1007\/s00044-022-02882-2","volume":"31","author":"EG Weagel","year":"2022","unstructured":"Weagel, E. G., Foulks, J. M., Siddiqui, A. & Warner, S. L. Molecular glues: enhanced protein\u2013protein interactions and cell proteome editing. Med Chem. Res. 31, 1068\u20131087 (2022).","journal-title":"Med Chem. Res."},{"key":"34582_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13527","volume":"512","author":"ES Fischer","year":"2014","unstructured":"Fischer, E. S. et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512, 49\u201353 (2014).","journal-title":"Nature"},{"key":"34582_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature16979","volume":"532","author":"G Petzold","year":"2016","unstructured":"Petzold, G., Fischer, E. S. & Thoma, N. H. Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase. Nature 532, 127\u2013130 (2016).","journal-title":"Nature"},{"key":"34582_CR41","doi-asserted-by":"publisher","unstructured":"Simonetta, K. R. et al. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nat. Comm. 10, ARTN 1402 https:\/\/doi.org\/10.1038\/s41467-019-09358-9 (2019).","DOI":"10.1038\/s41467-019-09358-9"},{"key":"34582_CR42","doi-asserted-by":"publisher","unstructured":"Miller, S. et al. Structural differences in the FAD-binding pockets and lid loops of mammalian CRY1 and CRY2 for isoform-selective regulation. Proc. Natl Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2026191118 (2021).","DOI":"10.1073\/pnas.2026191118"},{"key":"34582_CR43","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1158\/0008-5472.CAN-12-1994","volume":"73","author":"JH Lee","year":"2013","unstructured":"Lee, J. H., Gaddameedhi, S., Ozturk, N., Ye, R. & Sancar, A. DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells. Cancer Res. 73, 785\u2013791 (2013).","journal-title":"Cancer Res."},{"key":"34582_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mrfmmm.2004.08.022","volume":"576","author":"LD Attardi","year":"2005","unstructured":"Attardi, L. D. & Donehower, L. A. Probing p53 biological functions through the use of genetically engineered mouse models. Mutat. Res-Fund. Mol. M 576, 4\u201321 (2005).","journal-title":"Mutat. Res-Fund. Mol. M"},{"key":"34582_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215\u2013221 (1992).","journal-title":"Nature"},{"key":"34582_CR46","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10142-019-00680-5","volume":"19","author":"AD Cavga","year":"2019","unstructured":"Cavga, A. D. et al. Cryptochrome deletion in p53 mutant mice enhances apoptotic and anti-tumorigenic responses to UV damage at the transcriptome level. Funct. Integr. Genom. 19, 729\u2013742 (2019).","journal-title":"Funct. Integr. Genom."},{"key":"34582_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/febs.15360","volume":"288","author":"S Cal-Kayitmazbatir","year":"2021","unstructured":"Cal-Kayitmazbatir, S. et al. CRY1-CBS binding regulates circadian clock function and metabolism. FEBS J. 288, 614\u2013639 (2021).","journal-title":"FEBS J."},{"key":"34582_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.tips.2013.09.002","volume":"34","author":"AM Schroeder","year":"2013","unstructured":"Schroeder, A. M. & Colwell, C. S. How to fix a broken clock. Trends Pharm. Sci. 34, 605\u2013619 (2013).","journal-title":"Trends Pharm. Sci."},{"key":"34582_CR49","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cell.2006.08.023","volume":"126","author":"MA Lampson","year":"2006","unstructured":"Lampson, M. A. & Kapoor, T. M. Targeting protein stability with a small molecule. Cell 126, 827\u2013829 (2006).","journal-title":"Cell"},{"key":"34582_CR50","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1073\/pnas.1214266110","volume":"110","author":"MM Bellet","year":"2013","unstructured":"Bellet, M. M. et al. Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1. Proc. Natl Acad. Sci. USA 110, 3333\u20133338 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34582_CR51","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1073\/pnas.1005101107","volume":"107","author":"QJ Meng","year":"2010","unstructured":"Meng, Q. J. et al. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proc. Natl Acad. Sci. USA 107, 15240\u201315245 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34582_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-pharmtox-010617-052645","volume":"58","author":"Z Chen","year":"2018","unstructured":"Chen, Z., Yoo, S.-H. & Takahashi, J. S. Development and therapeutic potential of small-molecule modulators of circadian systems. Annu. Rev. Pharmacol. Toxicol. 58, 231\u2013252 (2018).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"34582_CR53","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1021\/cb400752k","volume":"9","author":"SK Chun","year":"2014","unstructured":"Chun, S. K. et al. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. ACS Chem. Biol. 9, 703\u2013710 (2014).","journal-title":"ACS Chem. Biol."},{"key":"34582_CR54","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1021\/jm400458q","volume":"56","author":"RP Trump","year":"2013","unstructured":"Trump, R. P. et al. Optimized chemical probes for REV-ERB\u03b1. J. Medicinal Chem. 56, 4729\u20134737 (2013).","journal-title":"J. Medicinal Chem."},{"key":"34582_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1021\/cb1002762","volume":"6","author":"N Kumar","year":"2011","unstructured":"Kumar, N. et al. Identification of SR3335 (ML-176): a synthetic ROR\u03b1 selective inverse agonist. ACS Chem. Biol. 6, 218\u2013222 (2011).","journal-title":"ACS Chem. Biol."},{"key":"34582_CR56","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbrc.2016.03.010","volume":"472","author":"Y Li","year":"2016","unstructured":"Li, Y., Xiong, W. & Zhang, E. E. The ratio of intracellular CRY proteins determines the clock period length. Biochem. Biophys. Res. Commun. 472, 531\u2013538 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"34582_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.molcel.2016.11.022","volume":"65","author":"KL Ode","year":"2017","unstructured":"Ode, K. L. et al. Knockout-rescue embryonic stem cell-derived mouse reveals circadian-period control by quality and quantity of CRY1. Mol. Cell 65, 176\u2013190 (2017).","journal-title":"Mol. Cell"},{"key":"34582_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2017.03.027","volume":"169","author":"A Patke","year":"2017","unstructured":"Patke, A. et al. Mutation of the human circadian clock gene <em>CRY1<\/em> in familial delayed sleep phase disorder. Cell 169, 203\u2013215.e213 (2017).","journal-title":"Cell"},{"key":"34582_CR59","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1073\/pnas.1106284108","volume":"108","author":"JH Lee","year":"2011","unstructured":"Lee, J. H. & Sancar, A. Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis. Proc. Natl Acad. Sci. USA\u00a0108, 10668 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34582_CR60","first-page":"1201","volume":"29","author":"A Oda","year":"2009","unstructured":"Oda, A. et al. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. Anticancer Res. 29, 1201\u20131209 (2009).","journal-title":"Anticancer Res."},{"key":"34582_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1570180810906050337","volume":"6","author":"P Armutlu","year":"2009","unstructured":"Armutlu, P., Ozdemir, M. E., Ozdas, S., Kavakli, I. H. & Turkay, M. Discovery of novel CYP17 inhibitors for the treatment of prostate cancer with structure-based drug design. Lett. Drug Des. Disco. 6, 337\u2013344 (2009).","journal-title":"Lett. Drug Des. Disco."},{"key":"34582_CR62","doi-asserted-by":"publisher","first-page":"e31787","DOI":"10.1371\/journal.pone.0031787","volume":"7","author":"B Cakir","year":"2012","unstructured":"Cakir, B. et al. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme. PLoS One 7, e31787 (2012).","journal-title":"PLoS One"},{"key":"34582_CR63","doi-asserted-by":"crossref","unstructured":"Ozcan, O., Gul, S. & Kavakli, I. H. in Computer Aided Chemical Engineering 50, 2025\u20132031 (Elsevier, 2021).","DOI":"10.1016\/B978-0-323-88506-5.50313-2"},{"key":"34582_CR64","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput Chem."},{"key":"34582_CR65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput Chem."},{"key":"34582_CR66","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature11964","volume":"496","author":"W Xing","year":"2013","unstructured":"Xing, W. et al. SCF(FBXL3) ubiquitin ligase targets cryptochromes at their cofactor pocket. Nature 496, 64\u201368 (2013).","journal-title":"Nature"},{"key":"34582_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-11-69","volume":"11","author":"N Ozber","year":"2010","unstructured":"Ozber, N. et al. Identification of two amino acids in the C-terminal domain of mouse CRY2 essential for PER2 interaction. BMC Mol. Biol. 11, 69 (2010).","journal-title":"BMC Mol. Biol."},{"key":"34582_CR68","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1074\/jbc.RA120.014333","volume":"295","author":"S Gul","year":"2020","unstructured":"Gul, S. et al. The Arg-293 of Cryptochrome1 is responsible for the allosteric regulation of CLOCK-CRY1 binding in circadian rhythm. J. Biol. Chem. 295, 17187\u201317199 (2020).","journal-title":"J. Biol. Chem."},{"key":"34582_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34433-4","volume":"8","author":"T Korkmaz","year":"2018","unstructured":"Korkmaz, T. et al. Opposite carcinogenic effects of circadian clock gene BMAL1. Sci. Rep. 8, 16023 (2018).","journal-title":"Sci. Rep."},{"key":"34582_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10142-020-00757-6","volume":"21","author":"H Emisoglu-Kulahli","year":"2021","unstructured":"Emisoglu-Kulahli, H. et al. Transcriptome analysis of the circadian clock gene BMAL1 deletion with opposite carcinogenic effects. Funct. Integr. Genomics 21, 1\u201316 (2021).","journal-title":"Funct. Integr. Genomics"},{"key":"34582_CR71","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/prot.26314","volume":"90","author":"H Gul","year":"2022","unstructured":"Gul, H. et al. Proteome analysis of the circadian clock protein PERIOD2. Proteins 90, 1315\u20131330 (2022).","journal-title":"Proteins"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34582-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T07:16:34Z","timestamp":1701328594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34582-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34582"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34582-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.21.453206","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"3 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The M47 studied in this paper is awarded of the following patent: WO2021137771A1 (World Intellectual Property Organization, Patent Cooperation Treaty). S.G., M.T., and I.H.K. are inventors in these patent applications, while Koc University is the assignee. The title of the patent is \u201c11-(4-chlorophenyl)\u22124-(2,3-dihydro-1h-indole-1-carbonyl)\u22123,11-dimethyl-5,10,dioxatricyclo[7.4.0.0,2,6,]trideca-1,3,6,8-tetraen-13-one and derivatives as destabilizer of cry1 for the treatment of circadian rhythm associated diseases and disorders\u201d. The invention provided an anticancer molecule against cancers harboring p53 mutations. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6742"}}